logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Communicating About Risks And Safe Use Of Medicines Real Life And Applied Research 1st Ed Priya Bahri

  • SKU: BELL-22477430
Communicating About Risks And Safe Use Of Medicines Real Life And Applied Research 1st Ed Priya Bahri
$ 31.00 $ 45.00 (-31%)

4.4

22 reviews

Communicating About Risks And Safe Use Of Medicines Real Life And Applied Research 1st Ed Priya Bahri instant download after payment.

Publisher: Springer Singapore;Adis
File Extension: PDF
File size: 7.19 MB
Author: Priya Bahri
ISBN: 9789811530128, 9789811530135, 9811530122, 9811530130
Language: English
Year: 2020
Edition: 1st ed.

Product desciption

Communicating About Risks And Safe Use Of Medicines Real Life And Applied Research 1st Ed Priya Bahri by Priya Bahri 9789811530128, 9789811530135, 9811530122, 9811530130 instant download after payment.

At the core of this book lies the question how to approach medicines, risks and communication as a researcher - or anybody planning and evaluating a communication intervention, or wanting to understand communication events in private and the media. With a view to tackle current shortcomings of communication systems and processes for improved implementation, patient satisfaction and health outcomes, a multilayered approach is presented. This combines multiple data types and methods to obtain a wider and deeper understanding of the major parties and their interactions, as well as the healthcare, social and political contexts of information flows, how they interfere and which impact they have. Illustrated with real life experiences of safety concerns with medicines, worldwide active experts discuss the methods and contributions their disciplines can offer. With considerations on terminologies, tabulated overviews on communication types and outcomes, a patient-centred vision and plain language for non-medical readers, the book creates a platform for multidisciplinary collaborations amongst researchers as well as practitioners from communications, healthcare, the social sciences and pharmacovigilance. Importantly, it advocates for an active role of patients and highlights the achievements and aspirations of patient organisations. Finally, the book suggests establishing an inclusive discipline of humanities and epidemiology of medicinal product risk communication to realise full research potential. The authors are driven by the curiosity for communication as the most human behaviour, and as good health is amongst the basic human needs, medicinal product risk communication is an exciting research field of high global relevance.

Related Products